Champions Oncology, Inc. (CSBR)
Total Valuation
CSBR has a market cap or net worth of $67.15 million. The enterprise value is $70.43 million.
Market Cap | 67.15M |
Enterprise Value | 70.43M |
Important Dates
The last earnings date was Tuesday, March 12, 2024, after market close.
Earnings Date | Mar 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
CSBR has 13.59 million shares outstanding. The number of shares has increased by 0.26% in one year.
Shares Outstanding | 13.59M |
Shares Change (YoY) | +0.26% |
Shares Change (QoQ) | +0.72% |
Owned by Insiders (%) | 25.56% |
Owned by Institutions (%) | 42.16% |
Float | 4.72M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | 22.88 |
PS Ratio | 1.36 |
Forward PS | 1.68 |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 1.43 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.60
Current Ratio | 0.60 |
Quick Ratio | 0.56 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -850.70% and return on invested capital (ROIC) is -168.98%.
Return on Equity (ROE) | -850.70% |
Return on Assets (ROA) | -32.60% |
Return on Capital (ROIC) | -168.98% |
Revenue Per Employee | $214,017 |
Profits Per Employee | -$42,296 |
Employee Count | 230 |
Asset Turnover | 1.65 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, CSBR has paid $70,000 in taxes.
Income Tax | 70,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.34% in the last 52 weeks. The beta is 0.40, so CSBR's price volatility has been lower than the market average.
Beta (1Y) | 0.40 |
52-Week Price Change | +20.34% |
50-Day Moving Average | 5.76 |
200-Day Moving Average | 5.93 |
Relative Strength Index (RSI) | 34.91 |
Average Volume (30 Days) | 8,404 |
Short Selling Information
The latest short interest is 62,578, so 0.46% of the outstanding shares have been sold short.
Short Interest | 62,578 |
Short Previous Month | 64,523 |
Short % of Shares Out | 0.46% |
Short % of Float | 1.33% |
Short Ratio (days to cover) | 15.96 |
Income Statement
In the last 12 months, CSBR had revenue of $49.22 million and -$9.73 million in losses. Loss per share was -$0.72.
Revenue | 49.22M |
Gross Profit | 19.74M |
Operating Income | -9.61M |
Pretax Income | -9.66M |
Net Income | -9.73M |
EBITDA | -7.67M |
EBIT | -9.66M |
Loss Per Share | -$0.72 |
Balance Sheet
The company has $4.47 million in cash and $7.74 million in debt, giving a net cash position of -$3.27 million or -$0.24 per share.
Cash & Cash Equivalents | 4.47M |
Total Debt | 7.74M |
Net Cash | -3.27M |
Net Cash Per Share | -$0.24 |
Equity / Book Value | -2.06M |
Book Value Per Share | -0.15 |
Working Capital | -8.77M |
Cash Flow
In the last 12 months, operating cash flow was -$5.01 million and capital expenditures -$1.71 million, giving a free cash flow of -$6.72 million.
Operating Cash Flow | -5.01M |
Capital Expenditures | -1.71M |
Free Cash Flow | -6.72M |
FCF Per Share | -$0.49 |
Margins
Gross margin is 40.09%, with operating and profit margins of -19.51% and -19.76%.
Gross Margin | 40.09% |
Operating Margin | -19.51% |
Pretax Margin | -19.62% |
Profit Margin | -19.76% |
EBITDA Margin | -15.57% |
EBIT Margin | -19.62% |
FCF Margin | -13.65% |
Dividends & Yields
CSBR does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.26% |
Shareholder Yield | -0.26% |
Earnings Yield | -14.49% |
FCF Yield | -10.01% |
Analyst Forecast
The average price target for CSBR is $7.50, which is 52.75% higher than the current price. The consensus rating is "Buy".
Price Target | $7.50 |
Price Target Difference | 52.75% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | 12.23% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on August 12, 2015. It was a reverse split with a ratio of 1:12.
Last Split Date | Aug 12, 2015 |
Split Type | Reverse |
Split Ratio | 1:12 |
Scores
CSBR has an Altman Z-Score of -2.76 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -2.76 |
Piotroski F-Score | 3 |